Company Description
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally.
It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.
In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles.
Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels.
Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets.
Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets.
Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
| Country | United States |
| Founded | 1970 |
| IPO Date | Sep 29, 2000 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 10,500 |
| CEO | Joseph W. Dziedzic |
Contact Details
Address: 5830 Granite Parkway., Suite 1150 Plano, Texas 75024 United States | |
| Phone | (214) 618-5243 |
| Website | integer.net |
Stock Details
| Ticker Symbol | ITGR |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001114483 |
| CUSIP Number | 45826H109 |
| ISIN Number | US45826H1095 |
| Employer ID | 16-1531026 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Joseph W. Dziedzic | President, Chief Executive Officer and Director |
| Diron Smith | Executive Vice President and Chief Financial Officer |
| McAlister C. Marshall II | Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Corporate Secretary |
| Kirk K. Thor | Executive Vice President and Chief Human Resources Officer |
| Payman Khales | President of Cardio and Vascular |
| John Harris | Executive Vice President of Global Operations and Manufacturing Strategy |
| Tom P. Thomas | Vice President, Corporate Controller and Principal Accounting Officer |
| Andrew Senn | Senior Vice President of Strategy, Business Development and Investor Relations |
| Margaret Carthy | Executive Vice President of Global Quality and Regulatory Affairs |
| Jim Stephens | President of Cardiac Rhythm Management and Neuromodulation |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 8, 2024 | ARS | Filing |
| Apr 8, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 8, 2024 | DEF 14A | Other definitive proxy statements |
| Feb 20, 2024 | 10-K | Annual Report |
| Feb 15, 2024 | 8-K | Current Report |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 30, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 22, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 10, 2024 | 8-K | Current Report |